MedTrace Logo

Neuromodulation to Facilitate the Effect of Ketamine

NCT01816958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2013-03-22

No results posted yet for this study

Summary

application of external neuromodulation along with ketamine infusion.

Conditions

Interventions

OTHER

co-administration of TMS and infused ketamine

co-administration of TMS and infused ketamine

Sponsors & Collaborators

  • The Neuroscience Center, LLC

    lead OTHER

Principal Investigators

  • Steven R Devore Best, M.D. · The Neuroscience Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01816958 on ClinicalTrials.gov